The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market was estimated to be $1,201.23 million in 2021 and is estimated to reach $1,848.76 million in 2031 with an expected CAGR of 4.4% from 2022 to 2031. A PTCA balloon catheter is a device having a balloon at the tip that may be inflated or deflated while in place to open, widen, or close a route. These are employed in surgical procedures, with the most common applications being coronary artery disease and stent placement. Increase in occurrences of cardiac disorder, surge in geriatric population, attractive reimbursement policies, and technical improvements are all contributing to the balloon catheter market's expansion.
The market for PTCA balloon catheter is growing, due to increase in frequency of lifestyle-related diseases and surge in geriatric population. This expansion can be ascribed to technology advancements and increase in the number of angioplasty procedures conducted, owing to minimally invasive nature of the surgery. Atherosclerosis can cause peripheral and coronary artery disease, which can lead to stroke, myocardial infarction, and/or cardiovascular mortality. Furthermore, rapid adoption of sophisticated technologies in the angioplasty segment, including as drug-eluting and cutting balloons, is expected to boost market expansion throughout the forecast period, particularly in developed countries. Furthermore, angioplasty balloons have a greater success rate than traditional angioplasty techniques, which is expected to drive market growth.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 as pandemic. The COVID-19 is predicted to have a detrimental impact on market growth. The current COVID-19 situation has resulted in limited population movement in hospitals. People are keen to avoid any form of surgery or diagnostic operations, with the exception of emergencies, to reduce the chance of contracting COVID-19. Furthermore, hospitals have relocated workers from cardiac departments to other departments in need, such as emergency departments or intensive care units (ICU). All of these variables are projected to have an impact on market growth. Nonetheless, this slowdown in growth is projected to be temporary, and the market is expected to rise significantly in the future.
The global PTCA balloon catheter market is segmented on the basis of product, compliance, delivery platform, and balloon material. On the basis of product, it is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Depending on delivery platform, it is bifurcated into over-the-wire and rapid exchange/monorail balloon catheters. As per the compliance, the PTCA balloon catheter market is categorized into semi-compliant and non-compliant. According to balloon material, it is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.
Key players in the value chain include Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC.
The market for PTCA balloon catheter is growing, due to increase in frequency of lifestyle-related diseases and surge in geriatric population. This expansion can be ascribed to technology advancements and increase in the number of angioplasty procedures conducted, owing to minimally invasive nature of the surgery. Atherosclerosis can cause peripheral and coronary artery disease, which can lead to stroke, myocardial infarction, and/or cardiovascular mortality. Furthermore, rapid adoption of sophisticated technologies in the angioplasty segment, including as drug-eluting and cutting balloons, is expected to boost market expansion throughout the forecast period, particularly in developed countries. Furthermore, angioplasty balloons have a greater success rate than traditional angioplasty techniques, which is expected to drive market growth.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 as pandemic. The COVID-19 is predicted to have a detrimental impact on market growth. The current COVID-19 situation has resulted in limited population movement in hospitals. People are keen to avoid any form of surgery or diagnostic operations, with the exception of emergencies, to reduce the chance of contracting COVID-19. Furthermore, hospitals have relocated workers from cardiac departments to other departments in need, such as emergency departments or intensive care units (ICU). All of these variables are projected to have an impact on market growth. Nonetheless, this slowdown in growth is projected to be temporary, and the market is expected to rise significantly in the future.
The global PTCA balloon catheter market is segmented on the basis of product, compliance, delivery platform, and balloon material. On the basis of product, it is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Depending on delivery platform, it is bifurcated into over-the-wire and rapid exchange/monorail balloon catheters. As per the compliance, the PTCA balloon catheter market is categorized into semi-compliant and non-compliant. According to balloon material, it is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.
Key players in the value chain include Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the percutaneous transluminal coronary angioplasty (ptca) balloon catheters market analysis from 2021 to 2031 to identify the prevailing percutaneous transluminal coronary angioplasty (ptca) balloon catheters market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the percutaneous transluminal coronary angioplasty (ptca) balloon catheters market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global percutaneous transluminal coronary angioplasty (ptca) balloon catheters market trends, key players, market segments, application areas, and PTCA balloon catheters market opportunity growth strategies.
Key Market Segments
By Product
- Normal balloon catheter
- Drug eluting balloon catheter
- Cutting balloon catheter
- Scoring balloon catheter
By Delivery Platform
- Rapid Exchange (RX) / Monorail balloon catheter
- Over-the-wire (OTW) balloon catheter
By Compliance
- Semi-Compliant
- Non-Compliant
By Balloon Material
- Polyolefin copolymer (POC)
- Polyethylene (PE)
- Polyethylene terephthalate (PET)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ALVI MEDICA
- ABOTT LABORATORIES
- BOSTON SCIENTIFIC CORPORATION
- BECTON, DICKINSON & COMPANY
- IVASCULAR
- RONSTIS
- KONINKLIJKE PHILLIPS
- MEDTRONIC PLC
- BALTON SP ZOO
- B.BRAUN MELSUNGEN AG
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY PRODUCT
CHAPTER 5: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM
CHAPTER 6: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE
CHAPTER 7: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL
CHAPTER 8: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market,' the percutaneous transluminal coronary angioplasty (ptca) balloon catheters market was valued at $1.2 billion in 2021, and is estimated to reach $1.8 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031.A PTCA balloon catheter is a medical device that consists of a guidewire and a catheter that is placed into the femoral artery in the leg or the radial artery in the arm to treat restricted blood arteries. A balloon catheter can also be used to unblock blocked or restricted coronary arteries caused by coronary artery disease using a minimally invasive method (CAD).
Rise in geriatric population, surge in number of minimally invasive surgeries, increase in hospitalization with an increase in cardiovascular disorders, rise in demand for angioplasty over conventional surgeries, due to its minimally invasive nature and better outcome, and increase in the number of catheterization laboratories are among the major factors driving the PTCA Balloon Catheters Market growth, among others. Furthermore, rise in technological breakthroughs & modernization in healthcare equipment surge in healthcare research and development activities, and growth in developing markets will generate new opportunities for the Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market.
One of the primary reasons driving the market value is the expanding geriatric population, which is accompanied by an increase in the prevalence of aortic disease, venous thromboembolism (VTE), and peripheral arterial disease (PAD) due to age-related changes in vascular structure and function. The number of elderly individuals in Asia-Pacific is increasing at an unprecedented rate, and the region's ageing population has already reached critical number and fuling the PTCA Balloon Catheters Market size.
The global PTCA balloon catheter market is segmented on the basis of product, compliance, delivery platform, and material. On the basis of products, the PTCA balloon catheter market can be segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. On the basis of delivery platform the PTCA balloon catheters market is bifurcated into over the wire and rapid exchange/monorail balloon catheters. On the basis of compliance the PTCA balloon catheter market is categorized into semi-compliant and non-compliant. On the basis of balloon material the PTCA balloon catheters market is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA
Based on product, normal balloon catheter is projected to record a 4.5% CAGR and reach 1,125.56 million by the end of the analysis period and the growth in the drug eluting balloon catheter segment is readjusted to a revised 2.1% CAGR for the next 7-year period.
Depending on delivery platform, it is bifurcated into over-the-wire and rapid exchange/monorail balloon catheters. Over-the-wire balloon catheters feature guidewire that tracks along the full length of catheter. Rapid exchange balloon catheters have guidewire along a short section which helps in saving time
Based on compliance, The semi-compliant balloons that are made of polyurethane and silicone are accounted to be the largest segment in 2021 with a revenue of $960.1 million. The non-compliant balloon catheters are expected to grow with a CAGR of 6.1% during the given forecast period.
Based on balloon material the PTCA balloon catheters market is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Polyolefin copolymer (POC) segment accounted to be the largest segment with a revenue of $672.35 million in 2021. Polyethylene (PE) segment accounted for the fastest growing segment with a CAGR 5.3% in the given forecast period.
Region wise, in 2021, North America held the major share in terms of revenue in the market, because of increased healthcare infrastructure, government initiatives, an increase in the rates of cardiac diseases, and rising healthcare expenditures in this region, North America has the largest market for PTCA Balloon Catheters Market share. The PTCA Balloon Catheters Market trends in North America is followed by Europe.
Due to rise in occurrences of coronary heart disease, surge in disposable income, increase in awareness toward heart diseases and associated treatments and better healthcare infrastructure in Asia, the PTCA balloon catheter market is ecpected to grow rapidly in the coming years.
Key findings of the Study
- The audit gives a top to bottom investigation of the PTCA Balloon Catheters Industry, with most recent things and future appraisals to explain the imminent investment pockets.
- It gives a quantitative investigation from 2021 to 2031 to engage the accomplices to gain by prevailing market opportunities.
- Wide investigation by product type and end user determines the various trends and prevailing opportunities in the different market.
- Complete examination of all land regions is given, which assist with determining the main opportunities.
- Key market players are profiled and their strategies are investigated totally to expect the relentless standpoint of the market.
Companies Mentioned
- ALVI MEDICA
- ABOTT LABORATORIES
- BOSTON SCIENTIFIC CORPORATION
- BECTON, DICKINSON & COMPANY
- IVASCULAR
- RONSTIS
- KONINKLIJKE PHILLIPS
- MEDTRONIC PLC
- BALTON SP ZOO
- B.BRAUN MELSUNGEN AG
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
